|
|
|
Age : 55 Public asset : 23,842,002 USD Linked companies :  Novartis AG |
|
|
|
Harry Werner Kirsch occupies the position of Chief Financial Officer at Novartis AG.
He is also on the board of 5 other companies.
In the past Mr. Kirsch occupied the position of CFO-Global Pharmaceutical Business at Procter & Gamble Co.
Mr. Kirsch received an undergraduate degree from Karlsruher Institut für Technologie.
|
| Current positions of Harry Werner Kirsch | |
|
| Name | Title |
Since |
Novartis AG
(Pharmaceuticals) |
Chief Financial Officer |
2013 | | Novartis International AG |
Member-Supervisory Board |
- | | Novartis Vaccines & Diagnostics, Inc. |
Director |
- | | Novartis Institutes for Biomedical Research, Inc. |
Director |
- | | Novartis Pharma AG |
Member-Supervisory Board |
- | | Novartis Pharma KK |
Vice Chairman |
- |
|
| Holdings of Harry Werner Kirsch | |
|
| Name | Equities | % | Valuation |
Novartis AG (NOVN)
(Pharmaceuticals) | 251,645 | 0.010% | 23,842,002 USD |
|
| Harry Werner Kirsch: Personal Network | |
|
|
© 2021 People and Ownership : 
|
|
|
| Harry Werner Kirsch : Connections | |
|
|
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
